{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:17:36Z","timestamp":1793506656247,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.03.112","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T14:38:05Z","timestamp":1462804685000},"page":"3549-3555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Human anthelminthic vaccines: Rationale and challenges"],"prefix":"10.1016","volume":"34","author":[{"given":"Peter J.","family":"Hotez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Strych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lustigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.112_bib0365","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and YLDs, for 301 acute and chronic diseases and injuries for 188 countires, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"GBD_Study_2013_Collaborators","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0370","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition","volume":"386","author":"DALYs GBD","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"GBD_Mortality_and_Causes_of_Death_Collaborators","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0380","doi-asserted-by":"crossref","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0385","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/clpt.2009.16","article-title":"Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases","volume":"85","author":"Hotez","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0390","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0020336","article-title":"Rapid-impact interventions: how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor","volume":"2","author":"Molyneux","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0395","series-title":"Neglected tropical diseases program","author":"USAID","year":"2015"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0400","first-page":"133","article-title":"Planning, requesting medicines and reporting for preventive chemotherapy","volume":"90","author":"WHO","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2016.03.112_bib0405","doi-asserted-by":"crossref","first-page":"D104","DOI":"10.1016\/j.vaccine.2011.06.024","article-title":"Enlarging the Audacious Goal: elimination of the world's high prevalence neglected tropical diseases","volume":"29","author":"Hotez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0410","doi-asserted-by":"crossref","first-page":"e2562","DOI":"10.1371\/journal.pntd.0002562","article-title":"Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts","volume":"7","author":"Keenan","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0415","first-page":"577","article-title":"Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico","volume":"90","author":"WHO","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0420","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2149\/tmh.2014-S03","article-title":"MDA-Lymphatic Filariasis","volume":"42","author":"Ichimori","year":"2014","journal-title":"Trop Med Health"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0425","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MOG.0000000000000025","article-title":"Global progress towards eliminating gastrointestinal helminth infections","volume":"30","author":"McCarty","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0430","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11908-015-0465-x","article-title":"Update on prevention and treatment of intestinal helminth infections","volume":"17","author":"Blair","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0435","doi-asserted-by":"crossref","first-page":"e1004033","DOI":"10.1371\/journal.ppat.1004033","article-title":"An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas","volume":"10","author":"Gaze","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0440","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/archdischild-2012-302338","article-title":"Global trends in neglected tropical disease control and elimination: impact on child health","volume":"98","author":"Barry","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0445","series-title":"Death to onchocerciasis and lymphatic filariasis","author":"D.O.L.F.","year":"2015"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0450","doi-asserted-by":"crossref","first-page":"e0003422","DOI":"10.1371\/journal.pntd.0003422","article-title":"The onchocerciasis vaccine for Africa\u2014TOVA\u2014initiative","volume":"9","author":"Hotez","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0455","doi-asserted-by":"crossref","first-page":"e0003664","DOI":"10.1371\/journal.pntd.0003664","article-title":"Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa","volume":"9","author":"Kim","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0460","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1586\/14760584.2015.1059281","article-title":"The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa","volume":"14","author":"Makepeace","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0465","doi-asserted-by":"crossref","first-page":"e0003938","DOI":"10.1371\/journal.pntd.0003938","article-title":"Human onchocerciasis modelling the potential long-term consequences of a vaccination programme","volume":"9","author":"Turner","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0470","first-page":"343","article-title":"Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar","volume":"81","author":"Albonico","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0475","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4269\/ajtmh.1997.57.25","article-title":"Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali","volume":"57","author":"De Clercq","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0480","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","article-title":"Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis","volume":"299","author":"Keiser","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0485","doi-asserted-by":"crossref","first-page":"e1417","DOI":"10.1371\/journal.pntd.0001417","article-title":"Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR","volume":"6","author":"Soukhathammavong","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0490","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0035-9203(95)90101-9","article-title":"Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area","volume":"89","author":"Albonico","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0495","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.vaccine.2010.12.004","article-title":"The potential economic value of a hookworm vaccine","volume":"29","author":"Lee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0500","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrmicro2438","article-title":"Developing vaccines to combat hookworm infection and intestinal schistosomiasis","volume":"8","author":"Hotez","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2016.03.112_bib0505","doi-asserted-by":"crossref","first-page":"B227","DOI":"10.1016\/j.vaccine.2012.11.034","article-title":"The human hookworm vaccine","volume":"31","author":"Hotez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0510","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1586\/14760584.2014.872035","article-title":"Advancing a multivalent \u2018Pan-anthelmintic\u2019 vaccine against soil-transmitted nematode infections","volume":"13","author":"Zhan","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0515","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0520","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach","volume":"21","author":"Bergquist","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0525","doi-asserted-by":"crossref","first-page":"e1961","DOI":"10.1371\/journal.pntd.0001961","article-title":"Break Out: urogenital schistosomiasis and Schistosoma haematobium infection in the post-genomic era","volume":"7","author":"Brindley","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0530","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/S0031182014001310","article-title":"Vaccines and diagnostics for zoonotic schistosomiasis japonica","volume":"142","author":"You","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0535","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0264-410X(97)00071-6","article-title":"Human schistosomiasis: potential long-term consequences of vaccination programmes","volume":"15","author":"Chan","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0540","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/pmic.200900393","article-title":"The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini","volume":"10","author":"Mulvenna","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0545","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1017\/S0031182013001005","article-title":"Control of Taenia solium taeniasis\/cysticercosis: past practices and new possibilities","volume":"140","author":"Lightowlers","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0550","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1542\/pir.36-8-341","article-title":"Worm infections in children","volume":"36","author":"Weatherhead","year":"2015","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0555","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/AOG.0000000000000025","article-title":"Helminth infections: a new global women's health agenda","volume":"123","author":"Hotez","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0560","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1371\/journal.pntd.0000291","article-title":"Hookworm-related anaemia among pregnant women: a systematic review","volume":"2","author":"Brooker","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0565","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0956462414523743","article-title":"Genital schistosomiasis and its unacknowledged role on HIV transmission in the STD intervention studies","volume":"25","author":"Kjetland","year":"2014","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0570","doi-asserted-by":"crossref","first-page":"e0003618","DOI":"10.1371\/journal.pntd.0003618","article-title":"Helminth elimination in the pursuit of sustainable development goals: a worm index for human development","volume":"9","author":"Hotez","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0575","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0030102","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria","volume":"3","author":"Hotez","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0580","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4269\/ajtmh.2007.77.88","article-title":"Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control","volume":"77","author":"Brooker","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0585","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1475-2875-5-99","article-title":"The co-distribution of Plasmodium falciparum and hookworm among African school children","volume":"5","author":"Brooker","year":"2006","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0590","doi-asserted-by":"crossref","first-page":"e3234","DOI":"10.1371\/journal.pntd.0003234","article-title":"Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa","volume":"8","author":"Ndeffo Mbah","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0595","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/eji.201141991","article-title":"Interferon regulatory factor modulation underlies the bystander suppression of malaria antigen-driven IL-12 and IFN-gamma in filaria-malaria co-infection","volume":"42","author":"Metenou","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0600","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/COH.0b013e3283522c3d","article-title":"Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum","volume":"7","author":"Metenou","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0605","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.epidem.2014.04.002","article-title":"Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities","volume":"7","author":"Ndeffo Mbah","year":"2014","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0610","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4269\/ajtmh.14-0444","article-title":"Age-stratified profiles of serum IL-6, IL-10, and TNF-alpha cytokines among Kenyan children with Schistosoma haematobium, Plasmodium falciparum, and other chronic parasitic co-infections","volume":"92","author":"Bustinduy","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0615","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12967-015-0600-3","article-title":"Effect of deworming on Th2 immune response during HIV-helminths co-infection","volume":"13","author":"Mulu","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0620","article-title":"New vaccines for the world's poorest people","author":"Hotez","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0625","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijpara.2014.04.006","article-title":"Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model","volume":"44","author":"Hess","year":"2014","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0630","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.4161\/hv.28872","article-title":"Optimization and revisions of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate","author":"Curti","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0635","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/21645515.2015.1036207","article-title":"Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine","volume":"11","author":"Seid","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0640","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.4161\/21645515.2014.980199","article-title":"New tools for NTD vaccines: a case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74","volume":"11","author":"Pearson","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0645","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ng.2875","article-title":"Genome of the human hookworm Necator americanus","volume":"46","author":"Tang","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0650","doi-asserted-by":"crossref","first-page":"e1704","DOI":"10.1371\/journal.pntd.0001704","article-title":"Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis","volume":"6","author":"Riveau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0655","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijpara.2015.03.004","article-title":"A quantitative proteomic analysis of the tegumental proteins from Schistosoma mansoni schistosomula reveals novel potential therapeutic targets","volume":"45","author":"Sotillo","year":"2015","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0660","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fimmu.2015.00213","article-title":"Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates","volume":"6","author":"Pearson","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0665","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00436-014-3879-8","article-title":"Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon","volume":"113","author":"Zhang","year":"2014","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0670","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00436-014-3757-4","article-title":"Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice","volume":"113","author":"Le","year":"2014","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0675","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/infdis\/jiu031","article-title":"Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons","volume":"209","author":"Karmakar","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0680","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.vaccine.2013.12.057","article-title":"Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons","volume":"32","author":"Karmakar","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0685","first-page":"6","article-title":"Development of the Brazilian anti Schistosomiasis vaccine based on the recombinant FABP Sm14 +GLA-SE","author":"Tendler","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0690","unstructured":"Klei TR. Efficacy studies of novel Brugia malayi homologs of Onchocerca volvulus recombinant protein vaccine candidates. Personal Communication."},{"key":"10.1016\/j.vaccine.2016.03.112_bib0695","unstructured":"Lustigman S. Immunomic profiling of the Ov-103 and Ov-RAL-2 vaccine candidates in Onchocerca volvulus exposed people from endemic areas of Cameroon. Unpublished results."},{"key":"10.1016\/j.vaccine.2016.03.112_bib0700","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/14760584.7.6.745","article-title":"Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis","volume":"7","author":"Hotez","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0705","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-065X.2010.00976.x","article-title":"Vaccines to combat the neglected tropical diseases","volume":"239","author":"Bethony","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0710","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1586\/14760584.2014.893195","article-title":"Vaccination against helminth parasite infections","volume":"13","author":"Hewitson","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0715","series-title":"WHO grants approval for safe, effective meningitis A vaccine for infants","author":"WHO","year":"2015"},{"key":"10.1016\/j.vaccine.2016.03.112_bib0720","doi-asserted-by":"crossref","first-page":"e0003672","DOI":"10.1371\/journal.pntd.0003672","article-title":"Blue marble health redux: neglected tropical diseases and human development in the group of 20 (G20) nations and Nigeria","volume":"9","author":"Hotez","year":"2015","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T16:01:31Z","timestamp":1600531291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16302596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":72,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16302596"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.112","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human anthelminthic vaccines: Rationale and challenges","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}